Orelabrutinib-Bruton Tyrosine Kinase Inhibitor-Based Regimens in the Treatment of Marginal Zone Lymphoma: A Retrospective Study

被引：0
|
作者：
Li, He [1 ]
Liu, Jiazhuo [1 ]
Chen, Yuhui [1 ]
Tuohuti, Pazilaiti [1 ]
Wang, Yutong [1 ]
Tang, Xinzhu [1 ]
Xiang, Bing [1 ]
Jia, Yongqian [1 ]
Wu, Yu [1 ]
Tang, Yun [1 ]
Guo, Yong [1 ]
Wang, Jie [1 ]
Zheng, Yuhuan [1 ]
Liu, Yu [1 ]
Niu, Ting [1 ,2 ,3 ]
机构：
[1] Sichuan Univ, West China Hosp, Dept Hematol, Chengdu, Peoples R China
[2] Sichuan Univ, West China Hosp, Natl Facil Translat Med Sichuan, Chengdu, Peoples R China
[3] Sichuan Univ, West China Hosp, Collaborat Innovat Ctr Biotherapy, State Key Lab Biotherapy, Chengdu, Peoples R China
来源：
BLOOD | 2024年 / 144卷
关键词：
D O I：
10.1182/blood-2024-206464
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：6308 / 6309
页数：2
相关论文
共 50 条
  • [41] Cost-Effectiveness of KTE-X19 Car T Therapy Following Bruton Tyrosine Kinase Inhibitor Treatment for Relapsed/Refractory Mantle Cell Lymphoma in England
    Maglinte, Gregory A.
    Simons, Claire L.
    Wang, Michael
    Wade, Sally W.
    Brown, Martin
    Petersohn, Svenja
    Bennison, Craig
    Dreyling, Martin
    BONE MARROW TRANSPLANTATION, 2021, 56 (SUPPL 1) : 195 - 196
  • [42] Egress of CD19+CD5+ Cells Into Peripheral Blood Following Treatment with the Bruton Tyrosine Kinase Inhibitor, PCI-32765, in Mantle Cell Lymphoma Patients
    Chang, Betty Y.
    Francesco, Michelle
    Magadala, Padmaja
    Huang, Min Mei
    Spaargaren, Marcel
    Buggy, Joseph J.
    Elias, Laurence
    BLOOD, 2011, 118 (21) : 436 - 436
  • [43] Multicenter Study of Mantle Cell Lymphoma Outcomes Following First-Line Bendamustine-Rituximab and Second-Line Bruton's Tyrosine Kinase Inhibitor Therapy
    Wang, Yucai
    Larson, Melissa C.
    Hwang, Steven R.
    Kumar, Anita
    Joseph, Ashlee
    Hill, Brian T.
    Brooks, Taylor R.
    Bond, David A.
    Maddocks, Kami J.
    Danilov, Alexey
    McCarthy, Christine
    Ruan, Jia
    Nizamuddin, Imran A.
    Kahl, Brad S.
    Grover, Natalie S.
    Khan, Nazneen B.
    Ouchveridze, Evguenia
    Tun, Aung M.
    Young, Philip
    Portell, Craig A.
    Harris, Zoey I.
    Munoz, Javier L.
    Reagan, Patrick M.
    Pongas, Georgio
    Lossos, Izidore S.
    Ryan, Christine E.
    Merryman, Reid W.
    Baidoun, Firas
    Moustafa, Muhamad Alhaj
    Gerber, Drew
    Ayyappan, Sabarish R.
    Link, Brian K.
    Velayati, Arash
    Greenwell, Irl Brian
    Banaszak, Lauren G.
    Pophali, Priyanka A.
    Stack, Anthony C.
    Messmer, Marcus R.
    Narkhede, Mayur
    Mehta, Amitkumar N.
    Jain, Preetesh
    Wang, Michael L.
    Moyo, Tamara K.
    Ghosh, Nilanjan
    Bhansali, Rahul S.
    Barta, Stefan K.
    Kamdar, Manali K.
    Anna, Jacob
    Stanisic, Alexander V.
    Karmali, Reem
    BLOOD, 2023, 142
  • [44] One-Year Efficacy and Safety Assessment of Ripasudil, a Rho Kinase Inhibitor, in an Addition to or Replacing Existing Treatment Regimens: A Retrospective Study
    Tsukahara, Shun
    Enomoto, Nobuko
    Ishida, Kyoko
    Anraku, Ayako
    Tomita, Goji
    JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS, 2020, 36 (07) : 512 - 521
  • [45] Efficacy and Safety of TACE Combined with a Tyrosine Kinase Inhibitor for the Treatment of TACE-Refractory Hepatocellular Carcinoma: A Retrospective Comparative Study
    Chen, Yu-Xing
    Zhang, Jin-Xing
    Zhou, Chun-Gao
    Liu, Jin
    Liu, Sheng
    Shi, Hai-Bin
    Zu, Qing-Quan
    Cheng, Yuan
    JOURNAL OF GASTROINTESTINAL CANCER, 2024, 55 (02) : 924 - 931
  • [46] Single Centre, Retrospective Study to Evaluate Treatment Outcomes Following Tyrosine Kinase Inhibitor for Chronic Gvhd Treatment Including Ruxolitinib, Ibrutinib and Imatinib
    Linn, Swe Mar
    Abduljalil, Omar
    Novitzky-Basso, Igor Nicolas
    Nampoothiri, Ram V.
    Pasic, Ivan
    Al-Shaibani, Zeyad
    Lam, Wilson
    Law, Arjun
    Michelis, Fotios
    Gerbitz, Armin
    Viswabandya, Auro
    Lipton, Jeffrey H.
    Kumar, Rajat
    Mattson, Jonas
    Kim, Dennis Dong Hwan
    BLOOD, 2020, 136
  • [47] Combination of Bruton's Tyrosine Kinase (BTK) inhibitor, ibrutinib, with rituximab versus placebo with rituximab in previously untreated patients with follicular lymphoma (FL): a randomized, phase 3 study (Perspective)
    Rule, S.
    Flinn, I.
    Chen, R.
    Kwei, L.
    Chu, A. D.
    Gordon, L. I.
    Fowler, N.
    BRITISH JOURNAL OF HAEMATOLOGY, 2020, 189 : 233 - 233
  • [48] Patient-reported outcomes (PROs) in Chinese patients with mantle cell lymphoma (MCL) after covalent Bruton's tyrosine kinase inhibitor (cBTKi) treatment: Post-hoc analysis from a phase II study
    Song, Y.
    Liu, Y.
    Lin, N.
    Yi, S.
    Huang, H.
    Guo, Y.
    Zhang, Q. Y.
    Yang, H.
    Zhang, H.
    Zhang, L.
    Feng, R.
    Qian, Y.
    Zhu, J.
    Ding, Y.
    Zhu, J.
    ANNALS OF ONCOLOGY, 2024, 35 : S1430 - S1430
  • [49] Treatment Effectiveness with Venetoclax-Based Therapy after Bruton Tyrosine Kinase Inhibitors in Chronic Lymphocytic Leukemia: An International Real-World Study
    Ghosh, Nilanjan
    Lamanna, Nicole
    Eyre, Toby A.
    Coombs, Catherine C.
    Manzoor, Beenish S.
    Brown, Jennifer R.
    Tuncer, Hande H.
    Ujjani, Chaitra S.
    Leslie, Lori A.
    Roeker, Lindsey E.
    Davids, Matthew S.
    Rhodes, Joanna M.
    Skarbnik, Alan
    Emechebe, Nnadozie
    Fleury, Isabelle
    Hill, Brian T.
    Fox, Christopher P.
    Barr, Paul M.
    Jawaid, Dureshahwar
    Sinai, Wendy J.
    Pearson, Laurie K.
    Lansigan, Frederick
    Choi, Yun
    Jensen, Christopher E.
    Schuster, Stephen J.
    Kennard, Kaitlin
    Pivneva, Irina
    Watson, Talissa
    Guerin, Annie
    Shadman, Mazyar
    BLOOD, 2023, 142
  • [50] Treatment Effectiveness of Venetoclax-Based Therapy After Bruton Tyrosine Kinase Inhibitors in Chronic Lymphocytic Leukemia: An International Real-World Study
    Ghosh, Nilanjan
    Eyre, Toby A.
    Brown, Jennifer R.
    Lamanna, Nicole
    Manzoor, Beenish S.
    Coombs, Catherine C.
    Tuncer, Hande H.
    Ujjani, Chaitra
    Leslie, Lori A.
    Roeker, Lindsey E.
    Davids, Matthew S.
    Rhodes, Joanna M.
    Skarbnik, Alan P.
    Sinai, Wendy
    Fleury, Isabelle
    Hill, Brian T.
    Martinez-Calle, Nicolas
    Barr, Paul M.
    Jawaid, Dureshahwar
    Emechebe, Nnadozie
    Pearson, Laurie
    Lansigan, Frederick
    Choi, Yun
    Jensen, Christopher E.
    Fakhri, Bita
    Stephens, Deborah M.
    Marx, Steven E.
    Schuster, Stephen J.
    Coyle, Michael
    Pivneva, Irina
    Watson, Talissa
    Guerin, Annie
    Shadman, Mazyar
    AMERICAN JOURNAL OF HEMATOLOGY, 2025, 100 (03) : 511 - 515
12345